Min Zhou

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Multidrug Resistant

Acinetobacter Baumannii

Long Non Coding Rna

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Mohamed Elbadawi, Joelle C Boulos, Mona Dawood, Min Zhou, Waseem Gul, Mahmoud A ElSohly, Sabine M Klauck, Thomas Efferth
The Novel Artemisinin Dimer Isoniazide ELI-XXIII-98-2 Induces c-MYC Inhibition, DNA Damage, and Autophagy in Leukemia Cells. Pharmaceutics 15 (4) (2023)
Mohamed Elbadawi, Joelle C Boulos, Mona Dawood, Min Zhou, Waseem Gul, Mahmoud A ElSohly, Sabine M Klauck, Thomas Efferth
The Novel Artemisinin Dimer Isoniazide ELI-XXIII-98-2 Induces c-MYC Inhibition, DNA Damage, and Autophagy in Leukemia Cells. Pharmaceutics 15 (4) (2023)
Mohamed Elbadawi, Joelle C Boulos, Mona Dawood, Min Zhou, Waseem Gul, Mahmoud A ElSohly, Sabine M Klauck, Thomas Efferth
The Novel Artemisinin Dimer Isoniazide ELI-XXIII-98-2 Induces c-MYC Inhibition, DNA Damage, and Autophagy in Leukemia Cells. Pharmaceutics 15 (4) (2023)
Mohamed Elbadawi, Joelle C Boulos, Mona Dawood, Min Zhou, Waseem Gul, Mahmoud A ElSohly, Sabine M Klauck, Thomas Efferth
The Novel Artemisinin Dimer Isoniazide ELI-XXIII-98-2 Induces c-MYC Inhibition, DNA Damage, and Autophagy in Leukemia Cells. Pharmaceutics 15 (4) (2023)